UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended April 1, 2017
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to .
Commission File Number: 001-36743
Apple Inc.
(Exact name of Registrant as specified in its charter)
California
94-2404110
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer Identification No.)
1 Infinite Loop
Cupertino, California
95014
(Address of principal executive offices)
(Zip Code)
(408) 996-1010
(Registrant s telephone number, including area code)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes No
Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).
Yes No
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
(Do not check if a smaller reporting company)
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes No
5,213,840,000 shares of common stock, par value $0.00001 per share, issued and outstanding as of April 21, 2017
Apple Inc.
Form 10-Q
For the Fiscal Quarter Ended April 1, 2017
TABLE OF CONTENTS
Page
Part I
Item 1.
Financial Statements
Item 2.
Management s Discussion and Analysis of Financial Condition and Results of Operations
23
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
32
Item 4.
Controls and Procedures
32
Part II
Item 1.
Legal Proceedings
33
Item 1A.
Risk Factors
33
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
43
Item 3.
Defaults Upon Senior Securities
43
Item 4.
Mine Safety Disclosures
43
Item 5.
Other Information
43
Item 6.
Exhibits
44
PART I FINANCIAL INFORMATION
Item 1.
Financial Statements
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(In millions, except number of shares which are reflected in thousands and per share amounts)
Three Months Ended
Six Months Ended
April 1,
2017
March 26,
2016
April 1,
2017
March 26,
2016
Net sales
52,896
50,557
131,247
126,429
Cost of sales
32,305
30,636
80,480
76,085
Gross margin
20,591
19,921
50,767
50,344
Operating expenses:
Research and development
2,776
2,511
5,647
4,915
Selling, general and administrative
3,718
3,423
7,664
7,271
Total operating expenses
6,494
5,934
13,311
12,186
Operating income
14,097
13,987
37,456
38,158
Other income/(expense), net
587
155
1,408
557
Income before provision for income taxes
14,684
14,142
38,864
38,715
Provision for income taxes
3,655
3,626
9,944
9,838
Net income
11,029
10,516
28,920
28,877
Earnings per share:
Basic
2.11
1.91
5.50
5.22
Diluted
2.10
1.90
5.46
5.19
Shares used in computing earnings per share:
Basic
5,225,791
5,514,381
5,262,226
5,536,656
Diluted
5,261,688
5,540,886
5,294,841
5,567,506
Cash dividends declared per share
0.57
0.52
1.14
1.04
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
(In millions)
Three Months Ended
Six Months Ended
April 1,
2017
March 26,
2016
April 1,
2017
March 26,
2016
Net income
11,029
10,516
28,920
28,877
Other comprehensive income/(loss):
Change in foreign currency translation, net of tax effects of $(44), $(19), $32 and $0, respectively
214
120
(161
18
Change in unrealized gains/losses on derivative instruments:
Change in fair value of derivatives, net of tax benefit/(expense) of $(25), $1, $(253) and $(37), respectively
(300
(178
1,168
109
Adjustment for net (gains)/losses realized and included in net income, net of tax expense/(benefit) of $311, $144, $100 and $210, respectively
(1,032
(528
(726
(973
Total change in unrealized gains/losses on derivative instruments, net of tax
(1,332
(706
442
(864
Change in unrealized gains/losses on marketable securities:
Change in fair value of marketable securities, net of tax benefit/(expense) of $(256), $(530), $733 and $(22), respectively
464
969
(1,344
47
Adjustment for net (gains)/losses realized and included in net income, net of tax expense/(benefit) of $7, $(27), $(4) and $(53), respectively
(13
49
96
Total change in unrealized gains/losses on marketable securities, net of tax
451
1,018
(1,337
143
Total other comprehensive income/(loss)
(667
432
(1,056
(703
Total comprehensive income
10,362
10,948
27,864
28,174
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(In millions, except number of shares which are reflected in thousands and par value)
April 1,
2017
September 24,
2016
ASSETS:
Current assets:
Cash and cash equivalents
15,157
20,484
Short-term marketable securities
51,944
46,671
Accounts receivable, less an allowance of $53 at each period end
11,579
15,754
Inventories
2,910
2,132
Vendor non-trade receivables
9,033
13,545
Other current assets
11,367
8,283
Total current assets
101,990
106,869
Long-term marketable securities
189,740
170,430
Property, plant and equipment, net
27,163
27,010
Goodwill
5,473
5,414
Acquired intangible assets, net
2,617
3,206
Other non-current assets
7,549
8,757
Total assets
334,532
321,686
LIABILITIES AND SHAREHOLDERS EQUITY:
Current liabilities:
Accounts payable
28,573
37,294
Accrued expenses
23,096
22,027
Deferred revenue
7,682
8,080
Commercial paper
9,992
8,105
Current portion of long-term debt
3,999
3,500
Total current liabilities
73,342
79,006
Deferred revenue, non-current
3,107
2,930
Long-term debt
84,531
75,427
Other non-current liabilities
39,470
36,074
Total liabilities
200,450
193,437
Commitments and contingencies
Shareholders equity:
Common stock and additional paid-in capital, $0.00001 par value: 12,600,000 shares authorized; 5,205,815 and 5,336,166 shares issued and outstanding, respectively
33,579
31,251
Retained earnings
100,925
96,364
Accumulated other comprehensive income/(loss)
(422
634
Total shareholders equity
134,082
128,249
Total liabilities and shareholders equity
334,532
321,686
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(In millions)
Six Months Ended
April 1,
2017
March 26,
2016
Cash and cash equivalents, beginning of the period
20,484
21,120
Operating activities:
Net income
28,920
28,877
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
5,319
5,431
Share-based compensation expense
2,473
2,126
Deferred income tax expense
2,822
3,092
Other
(209
308
Changes in operating assets and liabilities:
Accounts receivable, net
4,183
4,538
Inventories
(778
68
Vendor non-trade receivables
4,512
5,899
Other current and non-current assets
(896
186
Accounts payable
(6,862
(9,388
Deferred revenue
(221
219
Other current and non-current liabilities
316
(2,292
Cash generated by operating activities
39,579
39,064
Investing activities:
Purchases of marketable securities
(99,821
(86,242
Proceeds from maturities of marketable securities
12,429
9,148
Proceeds from sales of marketable securities
60,454
50,051
Payments made in connection with business acquisitions, net
(67
(140
Payments for acquisition of property, plant and equipment
(6,309
(5,948
Payments for acquisition of intangible assets
(126
(657
Payments for strategic investments
(126
Other
116
(196
Cash used in investing activities
(33,324
(34,110
Financing activities:
Proceeds from issuance of common stock
273
247
Excess tax benefits from equity awards
225
264
Payments for taxes related to net share settlement of equity awards
(788
(751
Payments for dividends and dividend equivalents
(6,134
(5,871
Repurchases of common stock
(18,012
(13,530
Proceeds from issuance of term debt, net
10,975
15,584
Change in commercial paper, net
1,879
(503
Cash used in financing activities
(11,582
(4,560
Increase/(Decrease) in cash and cash equivalents
(5,327
394
Cash and cash equivalents, end of the period
15,157
21,514
Supplemental cash flow disclosure:
Cash paid for income taxes, net
6,878
6,630
Cash paid for interest
1,007
565
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 Summary of Significant Accounting Policies
Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs, manufactures and markets mobile communication and media devices and personal computers, and sells a variety of related software, services, accessories, networking solutions and third-party digital content and applications. The Company s products and services include iPhone , iPad , Mac , Apple Watch , Apple TV , a portfolio of consumer and professional software applications, iOS, macOS , watchOS and tvOS operating systems, iCloud , Apple Pay and a variety of accessory, service and support offerings. The Company sells and delivers digital content and applications through the iTunes Store , App Store , Mac App Store, TV App Store, iBooks Store and Apple Music (collectively Digital Content and Services ). The Company sells its products worldwide through its retail stores, online stores and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the Company sells a variety of third-party Apple-compatible products, including application software and various accessories through its retail and online stores. The Company sells to consumers, small and mid-sized businesses and education, enterprise and government customers.
Basis of Presentation and Preparation
The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. In the opinion of the Company s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed consolidated financial statements have been reclassified to conform to the current period s presentation. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company's annual consolidated financial statements and the notes thereto included in its Annual Report on Form 10-K for the fiscal year ended September 24, 2016 (the 2016 Form 10-K ).
The Company s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. The Company s fiscal year 2017 will include 53 weeks and ends on September 30, 2017 and its fiscal year 2016 included 52 weeks and ended on September 24, 2016. A 14th week was included in the first quarter of 2017, as is done every five or six years, to realign fiscal quarters with calendar quarters. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.
Earnings Per Share
Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased by employees under the Company s employee stock purchase plan, unvested restricted stock and unvested restricted stock units ( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company s common stock can result in a greater dilutive effect from potentially dilutive securities.
The following table shows the computation of basic and diluted earnings per share for the three- and six-month periods ended April 1, 2017 and March 26, 2016 (net income in millions and shares in thousands):
Three Months Ended
Six Months Ended
April 1,
2017
March 26,
2016
April 1,
2017
March 26,
2016
Numerator:
Net income
11,029
10,516
28,920
28,877
Denominator:
Weighted-average shares outstanding
5,225,791
5,514,381
5,262,226
5,536,656
Effect of dilutive securities
35,897
26,505
32,615
30,850
Weighted-average diluted shares
5,261,688
5,540,886
5,294,841
5,567,506
Basic earnings per share
2.11
1.91
5.50
5.22
Diluted earnings per share
2.10
1.90
5.46
5.19
Potentially dilutive securities whose effect would have been antidilutive are excluded from the computation of diluted earnings per share.
Note 2 Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company s cash and available-for-sale securities by significant investment category as of April 1, 2017 and September 24, 2016 (in millions):
April 1, 2017
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
7,600
7,600
7,600
Level 1 (1):
Money market funds
2,742
2,742
2,742
Mutual funds
997
(120
877
877
Subtotal
3,739
(120
3,619
2,742
877
Level 2 (2):
U.S. Treasury securities
53,365
65
(300
53,130
2,280
16,067
34,783
U.S. agency securities
5,680
(10
5,673
687
3,687
1,299
Non-U.S. government securities
7,151
135
(67
7,219
193
7,026
Certificates of deposit and time deposits
6,386
6,386
921
4,665
800
Commercial paper
3,233
3,233
877
2,356
Corporate securities
147,939
643
(449
148,133
50
23,992
124,091
Municipal securities
950
(3
950
77
873
Mortgage- and asset-backed securities
21,086
31
(219
20,898
30
20,868
Subtotal
245,790
880
(1,048
245,622
4,815
51,067
189,740
Total
257,129
880
(1,168
256,841
15,157
51,944
189,740
September 24, 2016
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
8,601
8,601
8,601
Level 1 (1):
Money market funds
3,666
3,666
3,666
Mutual funds
1,407
(146
1,261
1,261
Subtotal
5,073
(146
4,927
3,666
1,261
Level 2 (2):
U.S. Treasury securities
41,697
319
(4
42,012
1,527
13,492
26,993
U.S. agency securities
7,543
16
7,559
2,762
2,441
2,356
Non-U.S. government securities
7,609
259
(27
7,841
110
818
6,913
Certificates of deposit and time deposits
6,598
6,598
1,108
3,897
1,593
Commercial paper
7,433
7,433
2,468
4,965
Corporate securities
131,166
1,409
(206
132,369
242
19,599
112,528
Municipal securities
956
961
167
794
Mortgage- and asset-backed securities
19,134
178
(28
19,284
31
19,253
Subtotal
222,136
2,186
(265
224,057
8,217
45,410
170,430
Total
235,810
2,186
(411
237,585
20,484
46,671
170,430
(1)
Level 1 fair value estimates are based on quoted prices in active markets for identical assets or liabilities.
(2)
Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The maturities of the Company s long-term marketable securities generally range from one to five years.
The Company considers the declines in market value of its marketable securities investment portfolio to be temporary in nature. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy generally requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates and the Company s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment s cost basis. As of April 1, 2017, the Company does not consider any of its investments to be other-than-temporarily impaired.
Derivative Financial Instruments
The Company may use derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future cash flows, on net investments in certain foreign subsidiaries and on certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates.
To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company s subsidiaries whose functional currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company may enter into forward contracts, option contracts or other instruments to manage this risk and may designate these instruments as cash flow hedges. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.
To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. In addition, the Company may use non-derivative financial instruments, such as its foreign currency-denominated debt, as economic hedges of its net investments in certain foreign subsidiaries. In both of these cases, the Company designates these instruments as net investment hedges.
The Company may also enter into non-designated foreign currency contracts to partially offset the foreign currency exchange gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies.
The Company may enter into interest rate swaps, options, or other instruments to manage interest rate risk. These instruments may offset a portion of changes in income or expense, or changes in fair value of the Company s term debt or investments. The Company designates these instruments as either cash flow or fair value hedges. The Company s hedged interest rate transactions as of April 1, 2017 are expected to be recognized within 10 years.
Cash Flow Hedges
The effective portions of cash flow hedges are recorded in accumulated other comprehensive income ( AOCI ) until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in other income/(expense), net in the same period as the related income or expense is recognized. The ineffective portions and amounts excluded from the effectiveness testing of cash flow hedges are recognized in other income/(expense), net.
Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified immediately into other income/(expense), net. Any subsequent changes in fair value of such derivative instruments are reflected in other income/(expense), net unless they are re-designated as hedges of other transactions.
Net Investment Hedges
The effective portions of net investment hedges are recorded in other comprehensive income ( OCI ) as a part of the cumulative translation adjustment. The ineffective portions and amounts excluded from the effectiveness testing of net investment hedges are recognized in other income/(expense), net.
Fair Value Hedges
Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change in value of the underlying hedged item.
Non-Designated Derivatives
Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates. As a result, during the three- and six-month periods ended April 1, 2017, respectively, the Company recognized a loss of $67 million and a gain of $206 million in net sales, a loss of $253 million and a gain of $79 million in cost of sales and a loss of $76 million and a gain of $432 million in other income/(expense), net.
The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company s accounting treatment for these derivative instruments is based on its hedge designation. The following tables show the Company s derivative instruments at gross fair value as of April 1, 2017 and September 24, 2016 (in millions):